Fine Organic Industries, a leader in oleochemical-based additives, faces a pivotal quarter as it balances domestic demand growth with significant international capacity expansion. Investors will be watching for updates on the margin trajectory amidst raw material price volatility and the status of major greenfield projects in India and the US.
| Results date | May 19, 2026 |
|---|---|
| Quarter | Q4 FY 2025-2026 |
| Previous quarter revenue | Rs. 554.8 Cr |
| Previous quarter PAT | Rs. 73.9 Cr |
| Previous quarter EBITDA margin | 17.0% |
| Market cap | Rs. 14,364.34 Cr |
| CMP | Rs. 4,685.05 |
The board meeting is scheduled for May 19, 2026, to consider and approve the audited consolidated and standalone financial results for Q4/FY26 and recommend a dividend for FY26 subject to AGM approval.
An earnings conference call is scheduled for May 21, 2026, at 3:30 p.m. IST, hosted by Chairman Mukesh Shah and CFO Sonali Bhadani.
In its most recently reported quarter, Fine Organic Industries posted revenue of Rs. 554.8 Cr, PAT of Rs. 73.9 Cr, and an EBITDA margin of 17.0%. Management has maintained a target of 5-6% volume growth over the next two years, supported by the E-73 plant which is nearing full capacity. The company continues to navigate raw material price volatility, noting that costs were absorbed in long-term contracts while passed on elsewhere. Strategic focus remains on the Rs. 700-750 Cr JNPA SEZ facility and establishing the US subsidiary in South Carolina, where 159.9 acres have been acquired. The upcoming call will likely address the impact of these capital-intensive expansions on cash deployment from the company's Rs. 1,150-1,200 Cr cash holdings.
Performance vs Guidance Tracking
Strategic execution and capex updates
Operating metric trajectory
Risks and headwinds to monitor
Fine Organic Industries will announce its Q4 FY 2025-2026 results on May 19, 2026.
Yes, the board meeting agenda includes the recommendation of a dividend for FY26, subject to AGM approval.
The company reported revenue of Rs. 554.8 Cr for the quarter ended December 31, 2025.
Management expects commercial production at the JNPA SEZ facility to commence in late 2027. The project involves a total capex of Rs. 700-750 Cr to be invested stage-wise.
Management confirmed that price increases were passed on to customers where no long-term contracts existed. However, for existing long-term contracts, the company absorbed the additional costs.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now